Risk Minimization/Mitigation in the Post-Marketing Arena, New Life Science Webinar Hosted by Xtalks
Toronto, Canada (PRWEB) October 24, 2013 -- Complex pharmacovigilance legislation in an evolving regulatory landscape have left drug makers searching for current, efficient and more meaningful solutions for their drug safety challenges especially in the post-marketing arena. Now more than ever, companies seek expert advice and customized approaches to effectively collect, manage and analyze real-world evidence.
In this presentation, PRA’s late-phase and risk management experts will examine unique strategies they have developed from years of significant first-hand experience in this area. Attendees will get industry-leading insights, tips and answers to urgent risk management-planning and drug safety questions and concerns. They will also benefit from informative best practices, lessons learned and case studies.
For more information about this event or to register, visit: http://xtalks.com/Risk-Minimization-in-the-Post-Marketing-Arena.ashx
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com
Client Services, Xtalks, +1 (416) 977-6555 227, [email protected]
Share this article